Encoded Therapeutics

denovirus transmission replication treatments 3D scientific illustration
Biotech

Encoded executes $275M series F to advance Dravet drug

Neuro-focused Encoded Therapeutics has bagged a $275 million series F round to support its Dravet syndrome asset and scale up its internal manufacturing capabilities.
Will Maddox Sep 9, 2026 9:42am
Alps parachute rainbow mountains

Pfizer RNA leader runs to Replicate—Chutes & Ladders

Dec 19, 2025 8:30am
DNA strand

Encoded deciphers pivotal path with phase 1/2 gene therapy data

Dec 5, 2025 12:45pm
workers

Encoded lays off 29% of staff to fund Dravet gene therapy trial

Feb 13, 2025 10:20am
layoffs boardroom restructuring layoff

Encoded lays off 10% of staff after back-to-back $100M+ rounds

Jun 13, 2023 3:25pm
3D medical background with DNA strand

Next-gen gene therapies for rare diseases forge ahead

Dec 14, 2020 5:28am